Galapagos NV

Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL

12 Jun 2025 13:01:00 By Nasdaq GlobeNewswire

Galapagos Creates New Subscription Right Plan

27 May 2025 13:33:01 By Nasdaq GlobeNewswire

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101

14 May 2025 13:01:00 By Nasdaq GlobeNewswire

Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes

12 May 2025 22:35:54 By Nasdaq GlobeNewswire

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

23 Apr 2025 13:01:00 By Nasdaq GlobeNewswire

Galapagos Announces Executive Leadership Updates

21 Apr 2025 13:10:00 By Nasdaq GlobeNewswire

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025

14 Apr 2025 22:30:00 By Nasdaq GlobeNewswire

Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting

27 Mar 2025 13:01:00 By Nasdaq GlobeNewswire

Galapagos to Present at Upcoming Investor Conferences

24 Feb 2025 13:01:00 By Nasdaq GlobeNewswire

Galapagos receives transparency notification and 13D filing from Tang Capital

17 Feb 2025 13:01:00 By Nasdaq GlobeNewswire

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

12 Feb 2025 13:01:00 By Nasdaq GlobeNewswire

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

07 Jan 2025 22:30:00 By Nasdaq GlobeNewswire

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

07 Jan 2025 13:01:00 By Nasdaq GlobeNewswire

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

07 Dec 2024 09:30:00 By Nasdaq GlobeNewswire

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

05 Nov 2024 13:01:00 By Nasdaq GlobeNewswire

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

30 Oct 2024 13:01:00 By Nasdaq GlobeNewswire

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

06 Oct 2024 21:59:59 By Nasdaq GlobeNewswire

Galapagos receives transparency notification from EcoR1 Capital

30 Sep 2024 13:01:00 By Nasdaq GlobeNewswire

Galapagos receives transparency notification from EcoR1 Capital

16 Sep 2024 13:01:00 By Nasdaq GlobeNewswire

Galapagos receives transparency notification from FMR LLC

03 Sep 2024 13:01:00 By Nasdaq GlobeNewswire